血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识(2018年版)》解读

2018-05-30 中华血液学杂志.2018.39(5):370-371.

B细胞慢性淋巴增殖性疾病

《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识》（2018 年版）已发表，共识中对各种疾病类型的特征和主要的诊断、鉴别诊断要点进行了描述。本文我们仅就其中几个关键问题进行梳理说明，希望有助于大家理解和把握重点。

中文标题：

《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识(2018年版)》解读

发布机构：

发布日期：

2018-05-30

简要介绍：

《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识》（2018 年版）已发表，共识中对各种疾病类型的特征和主要的诊断、鉴别诊断要点进行了描述。本文我们仅就其中几个关键问题进行梳理说明，希望有助于大家理解和把握重点。 

作者： 北京协和医学院血液病医院 李增军 邱录贵

拓展指南：与B细胞相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识(2018年版)》解读)] GetToolGuiderByIdResponse(projectId=1, id=98fdd1c0016093ff, title=《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识(2018年版)》解读, enTitle=, guiderFrom=中华血液学杂志.2018.39(5):370-371., authorId=null, author=, summary=《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识》（2018 年版）已发表，共识中对各种疾病类型的特征和主要的诊断、鉴别诊断要点进行了描述。本文我们仅就其中几个关键问题进行梳理说明，希望有助于大家理解和把握重点。 , cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed May 30 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识》（2018 年版）已发表，共识中对各种疾病类型的特征和主要的诊断、鉴别诊断要点进行了描述。本文我们仅就其中几个关键问题进行梳理说明，希望有助于大家理解和把握重点。 </div> <div><br> </div>作者： 北京协和医学院血液病医院 李增军 邱录贵 <div><br> </div> 拓展指南：<strong>与<font color=red>B细胞</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=ba6a41c00159a379" title="NCCN临床实践指南：B细胞淋巴瘤（2018.V4）" target=_blank>NCCN临床实践指南：B细胞淋巴瘤（2018.V4）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d20c71c0015836e0" title="NCCN临床实践指南：B细胞淋巴瘤（2018.V3）" target=_blank>NCCN临床实践指南：B细胞淋巴瘤（2018.V3）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=12d431c0015e05ea" title="NCCN临床实践指南：B细胞淋巴瘤（2018.V2）" target=_blank>NCCN临床实践指南：B细胞淋巴瘤（2018.V2）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=5a7de1c00155a0d7" title="2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用" target=_blank>2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=07ca21c0015510cf" title="NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V2）" target=_blank>NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V2）</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=B%E7%BB%86%E8%83%9E" target=_blank>有关B细胞更多指南</a></ul>, tagList=[TagDto(tagId=76981, tagName=B细胞慢性淋巴增殖性疾病)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4388, appHits=206, showAppHits=3, pcHits=3255, showPcHits=1995, likes=70, shares=7, comments=3, approvalStatus=1, publishedTime=Fri Jun 29 22:36:56 CST 2018, publishedTimeString=2018-05-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Jun 29 22:36:56 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 07:01:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识(2018年版)》解读)])
《B细胞慢性淋巴增殖性疾病诊断与鉴别诊断中国专家共识(2018年版)》解读
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=328096, encodeId=f005328096db, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Jun 30 06:15:26 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328052, encodeId=a9573280529c, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Jun 29 23:43:25 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328046, encodeId=245432804614, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Fri Jun 29 23:32:08 CST 2018, time=2018-06-29, status=1, ipAttribution=)]
    2018-06-30 1dd8c52fm63(暂无匿称)

    了解了解.继续关注

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=328096, encodeId=f005328096db, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Jun 30 06:15:26 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328052, encodeId=a9573280529c, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Jun 29 23:43:25 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328046, encodeId=245432804614, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Fri Jun 29 23:32:08 CST 2018, time=2018-06-29, status=1, ipAttribution=)]
    2018-06-29 清风拂面

    谢谢分享学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=328096, encodeId=f005328096db, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sat Jun 30 06:15:26 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328052, encodeId=a9573280529c, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Jun 29 23:43:25 CST 2018, time=2018-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328046, encodeId=245432804614, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Fri Jun 29 23:32:08 CST 2018, time=2018-06-29, status=1, ipAttribution=)]
    2018-06-29 329523732

    不错

    0